News
Elon Musk’s Neuralink targets human trials for brain-machine interface in 2020
After operating in stealth mode for the past two years, Neuralink, the brain-machine interface startup co-founded by SpaceX and Tesla CEO Elon Musk, has revealed some of the innovations that it has been developing. The company also announced that it is aiming to start implanting devices in humans by 2020, starting with paralyzed individuals who could then control phones or computers through their brain-machine implants.
Neuralink focused on two innovations on Tuesday’s presentation. The first involved flexible “threads” that are incredibly thin, measuring between 4 and 6 μm or about 1/3 the diameter of human hair. These threads are capable of transferring high volumes of data, with a white paper published by the company hinting at “as many as 3,072 electrodes per array distributed across 96 threads.” With the threads being incredibly thin, they would not damage the brain.
Another key technology revealed by Neuralink on its recent presentation was a custom made robot designed to embed implants into the brain. Thanks to computer vision and lenses, the robot will be able to place implants on patients without hitting or damaging blood vessels, reducing damage to the brain and scar tissue. Neuralink researcher Philip Sabes noted that “because these things are so thin and flexible, the idea is that they move with the tissue instead of tearing the tissue.”
Neuralink has performed at least 19 surgeries on animals with its robots, and so far, the machines have successfully placed the threads about 87% of the time. One of these subjects, a rather hefty rat that was shown off to the press, was fitted with a wired prototype of the company’s brain-machine interface. During the press demo, Sabes mentioned that the amount of data gathered from the rodent was about ten times greater than what is possible with today’s sensors.
In his presentation, Elon Musk stated that the evolution of Neuralink’s tech would be gradual, though he did mention that the company’s goal is a form of “symbiosis” with technology. “It’s not going to be suddenly Neuralink will have this neural lace and start taking over people’s brains. This is going to sound pretty weird, but ultimately, we will achieve symbiosis with artificial intelligence. This is not a mandatory thing. It is a thing you can choose to have if you want. This is something that I think will be really important on a civilization-level scale,” he remarked.
While the technologies shared by Neuralink on Tuesday seemed borderline science fiction, Neuralink president Max Hodak noted that similar innovations have actually been introduced and implemented in the past. “Neuralink didn’t come out of nowhere; there’s a long history of academic research here. We’re, in the greatest sense, building on the shoulders of giants,” he said. Nevertheless, Neuralink’s goal of directly reading neural spikes in a minimally-intrusive way remains notably ambitious.
The potential for such technologies is enormous. Implants such as BrainGate, which was developed initially at Brown University, were used in cases such as those of Matthew Nagle, who suffered from a spinal cord injury. Back in 2006, Nagle was able to learn how to use a computer using brain implants, at one point even playing Pong with his mind. In its presentation, Neuralink noted that its brain implants could be used for several individuals afflicted by Parkinson’s Disease, Dystonia, Epilepsy, OCD, Depression, Chronic Pain, and Tinnitus, among many.
Yet, despite its impressive innovations and its lofty goals, it should be noted that Neuralink is still a long way from achieving its targets. Dr. Matthew MacDougall, head surgeon at Neuralink, mentioned this while discussing how Neuralink implants could be as seamless as Lasik in the future. “There is a whole FDA process we have to go though. We haven’t done that yet,” he said.
So why the presentation? As noted by Elon Musk, Tuesday’s event is, at its core, an invitation for interested individuals who would like to work on the innovations that Neuralink is pursuing. With this open invitation, it would not be surprising if the company attracts an impressive number of talent in the near future. But now it’s time for you to vote. Will you be open to getting a brain-machine interface implant from Neuralink in the future?
Tesla stock (NASDAQ: TSLA) endured one of its sharpest single-day declines in years on July 23, tumbling approximately 14.5 percent and closing near $320 after opening the session around $374. The drop erased more than $140 billion in market value amid heavy trading volume and left the shares at multi-week lows.
The sell-off followed the company’s second-quarter 2026 results, released the previous evening. Tesla reported record revenue of $28.2 billion, up 26 percent year over year, driven by a Q2-record 480,126 vehicle deliveries. Energy storage deployments also rose strongly.
Tesla (TSLA) Q2 2026 earnings results: miss on EPS, beat on revenue
Yet profitability disappointed sharply. Operating income fell 57 percent to $398 million, compressing the operating margin to just 1.4 percent. Non-GAAP earnings per share came in at $0.33, well below the roughly $0.53 analysts had expected. Free cash flow turned negative by $1.1 billion as capital expenditures surged 142 percent to $5.8 billion, largely tied to accelerated spending on artificial intelligence, robotics, and autonomous systems.
The losses on capex were expected, as Tesla said it would be spending heavily in 2026.
Investors also reacted to lingering uncertainty surrounding key product timelines. During the Earnings Call, management reiterated ambitions for Robotaxi deployment and the Optimus humanoid robot, but offered limited new concrete milestones, renewing questions about execution pace that have long accompanied Tesla’s ambitious roadmap.
The magnitude of the decline places it among Tesla’s more severe one-day percentage losses since its 2010 initial public offering. Historically, the two largest single-day drops (split-adjusted) remain September 8, 2020, when shares fell 21.1 percent amid broader market volatility and valuation concerns, and January 13, 2012, with a 19.3 percent plunge during the company’s early growth struggles.
Other notable declines include an 18.6 percent drop on March 16, 2020, at the onset of pandemic-related market turmoil. Thursday’s move ranks roughly ninth on the all-time list but stands out as the steepest in more than a year.
Despite the short-term pain, Tesla’s long-term trajectory has repeatedly recovered from such volatility. The latest results underscore both the strength of its core automotive and energy businesses and the near-term costs of heavy investment in next-generation technologies.
Elon Musk clapped back at France’s decision to withhold the approval for Tesla’s Full Self-Driving (FSD) Supervised system, projecting a clear and blunt message to French Transport Minister Phillippe Tabarot, after he publicly rejected the technology in its current form.
Tabarot outlines several concerns with Tesla Full Self-Driving in a detailed video statement, where he said, “The safety trade-offs are not yet sufficient to authorize it as it currently stands,” he said. He emphasized that FSD is not a true self-driving system and that the driver remains fully responsible.
Key issues Tabarot also brought up included allowing speeding when surrounding traffic exceeds limits and what he believes are insufficient guarantees of driver attention during complex urban maneuvers such as lane changes, intersections, and roundabouts.
Delaying the approval of FSD in France will cost lives
— Elon Musk (@elonmusk) July 22, 2026
While acknowledging technological progress and France’s support for autonomous innovation, Tabarot stressed that deployment must prioritize road safety. He noted ongoing technical discussions with Tesla, the Netherlands, and other European partners, with further ecosystem meetings planned for the fall.
Musk’s rebuke highlights the human cost of regulatory caution. Tesla’s latest safety reports provide compelling data supporting accelerated adoption. In the most recent 12-month period, vehicles using FSD (Supervised) recorded one major collision per approximately 5.1 million miles driven, dramatically better than the U.S. national average of one crash per 698,000 miles.
Even Tesla vehicles driven manually with active safety features outperform the average by a wide margin. These figures come from billions of real-world miles of telemetry, showing FSD vehicles involved in far fewer incidents than both manual Teslas and the broader U.S. fleet.
Critics argue Tesla’s comparisons require careful scrutiny regarding reporting thresholds and fleet demographics, yet the data consistently positions FSD as a potential lifesaver. With road fatalities remaining a leading cause of death worldwide, Musk contends that proven safer technology should not face prolonged bureaucratic hurdles.
France’s measured approach reflects the broader European regulatory caution, which many, especially Musk, have been critical of in the past. However, as autonomous systems from Tesla and competitors like Waymo demonstrate superior safety in independent studies, pressure is mounting for harmonized approvals.
Musk’s warning carries the belief that every month of delay may equate to avoidable tragedies on European roads.
In a striking revelation that underscores the lucrative crossover between Big Tech and space exploration, Alphabet Inc., Google’s parent company, disclosed a massive $94.1 billion equity stake in SpaceX following the rocket company’s blockbuster initial public offering earlier this year.
The disclosure came in Alphabet’s quarterly filing, marking the first time the long-held private investment has been publicly valued at market prices. Google was an early backer, investing alongside Fidelity in 2015 with roughly $500-900 million at a time when SpaceX was valued around $12 billion.
That bet has delivered extraordinary returns, roughly a hundredfold, transforming a strategic play on satellite internet and launch capabilities into one of Alphabet’s largest assets.
Google, $GOOGL, has said they hold $94 billion in SpaceX, $SPCX, shares after IPO.
— unusual_whales (@unusual_whales) July 23, 2026
Of the total holding, approximately $80 billion remains subject to short-term post-IPO lockup restrictions, preventing near-term sales. An additional $14.1 billion faces longer-term restrictions, extending into the third quarter of 2027. This structure limits immediate liquidity but protects against market volatility as SpaceX transitions into public trading.
The SpaceX position contributed significantly to gains in Alphabet’s broader investment portfolio, which also includes a major stake in AI leader Anthropic. Combined, these holdings helped drive nearly $100 billion in investment gains during the second quarter, providing a substantial boost to net income amid ongoing AI spending pressures.
Analysts view the disclosure as validation of Alphabet’s venture strategy beyond its core search and cloud businesses. The investment aligns with deeper ties, including reported multi-billion-dollar deals for AI computing capacity on SpaceX infrastructure. As SpaceX advances Starship flights, Starlink expansion, and ambitious Mars goals under Elon Musk, Google’s stake positions it to benefit from the commercialization of space.
For Alphabet, the windfall highlights how patient, forward-looking bets in transformative sectors can yield outsized rewards. While lockups temper short-term impact, the holding cements SpaceX as a cornerstone of Alphabet’s diversified portfolio in an era where aerospace, AI, and connectivity increasingly intersect. Investors will watch closely as restrictions lift and SpaceX’s public performance unfolds.
Tesla stock tumbles after earnings, one of its sharpest single-day declines
Elon Musk is not happy about this Tesla Full Self-Driving approval delay
